Product Details

Teva-Diclofenac SR

Diclofenac Sodium
75 mg
LA Tablet


DIN/PIN/NPN

02158582

Manufacturer

Teva Canada Limited

Formulary Listing Date

1998-12-31  

Unit Price

0.4529

Amount MOH Pays

0.4529

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Diclofenac Sodium 75 mg LA Tablet: NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.

ATC Code

M01AB05

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
00782459 Voltaren SR NA NA
02158582 Teva-Diclofenac SR 0.4529 0.4529
02162814 Apo-Diclo SR 0.4529 0.4529
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph